SOURCE: BIOSAFE Medical Technologies, Inc.

August 02, 2005 08:50 ET

BIOSAFE Receives European Approval for Anemia Meter Sales

LAKE FOREST, IL -- (MARKET WIRE) -- August 2, 2005 -- BIOSAFE Medical Technologies, Inc. announced today it has been granted a Product Certificate of Registration, or CE Marking, for its rapid response Anemia Meter. The BIOSAFE Anemia Meter is the first disposable blood test for anemia detection. Designed and developed by BIOSAFE's research and development team at BIOSAFE Laboratories, Inc., the test produces an instant result that is both easy to understand and as accurate as a standard laboratory analysis.

European legislation requires manufacturers to display CE Marking on their products, packaging and accompanying literature. The CE Marking on a product allows it to be legally placed on the European market, assures its free movement within the member countries, and warranties that the product complies with relevant European health, safety and environmental protection legislations. In December 2004, the Food and Drug Administration granted approval for the sale of the BIOSAFE Anemia Meter in the United States.

Anemia is a blood condition identified by a lower than normal number of red blood cells, usually measured by a decrease in the amount of hemoglobin. Hemoglobin is the red pigment in red blood cells that transports oxygen throughout the body. Risk factors for anemia include heavy menstrual periods, pregnancy and older age, as well as serious diseases that cause anemia such as chronic kidney disease, diabetes, heart disease, cancer, rheumatoid arthritis, inflammatory bowel disease, and HIV.

"Our goal is to bring products to market that benefit both the healthcare professional and the consumer. The BIOSAFE Anemia Meter provides a quick, easy and reliable way for physicians to test for anemia in their offices or for the consumer to screen for anemia at home," said BIOSAFE's Chief Science Officer, Jack Maggiore, PhD.

BIOSAFE is best known for its trademark collection methods and patented blood transport systems, but the BIOSAFE Anemia Meter is the first of a series of new products that produces an immediate result. "While we feel the market for self-collected laboratory testing will continue to grow," offered BIOSAFE President David Fleisner, "it's clear that there is a demand for testing that is convenient, accurate and provides an immediate result to the user. Our CE Marking approval now allows us access to the entire European market and the millions of people this device will benefit."

BIOSAFE Medical Technologies, Inc. is a world leader in the development of micro blood sample testing technology. Located in Chicago, Illinois, BIOSAFE Laboratories, Inc. is a subsidiary of BIOSAFE Medical Technologies, Inc. and develops, manufactures, and processes health monitoring and screening products for the diabetes, women's health, men's health, and heart health markets.

Contact Information

  • For more information, contact:
    David Fleisner
    fax 847-234-8222
    Email Contact